Cataract surgery – Medxy AI

Increased Risk of Pseudophakic Cystoid Macular Edema After Cataract Surgery in Eyes with Prior Pars Plana Vitrectomy: Insights from a Large Retrospective Cohort Study

By MedXY 08/02/2026

This study reveals that eyes with previous pars plana vitrectomy exhibit a significantly higher risk of cystoid macular edema following cataract surgery, underscoring the need for careful postoperative monitoring and potential prophylaxis strategies.

Infectious Diseases news Ophthalmology

Fungal Endophthalmitis Associated with Contaminated Trypan Blue in Cataract Surgery: A Retrospective Case Series

By MedXY 07/24/2026

Six cases of postoperative fungal endophthalmitis caused by Sarocladium kiliense following cataract surgery involving contaminated trypan blue are reported, highlighting diagnosis, management, and outcomes.

news Ophthalmology

Assessing the Impact of Cataract Surgery on Progression from Dry to Neovascular Age-Related Macular Degeneration: Insights from the IRIS® Registry

By MedXY 06/25/2026

A large retrospective study from the IRIS® Registry reveals a modest, time-dependent increase in neovascular AMD risk following cataract surgery in patients with dry AMD, with implications for perioperative evaluation and patient counseling.

Clinical Updates news Ophthalmology

Clobetasol Propionate Ophthalmic Suspension 0.05%: A New Therapeutic Milestone in Post-Cataract Surgery Inflammation and Pain Management

By MedXY 05/11/2026

This review synthesizes clinical evidence for CPN 0.05% (BYQLOVI®), highlighting its rapid efficacy, superior pain resolution, and favorable safety profile compared to traditional ocular steroids following cataract surgery.

news Ophthalmology Public Health

Most Patients Reach 20/40 After Cataract Surgery, but the Current MIPS Success Metric May Misclassify Quality and Exclude Nearly Half of Cases

By MedXY 05/09/2026

A large multicenter study found that MIPS measure 191 captures high cataract surgery success rates but excludes many patients and may require case-mix adjustment to support fair surgeon comparisons.

news Ophthalmology

High Glaucoma Risk in Pseudoexfoliation Syndrome: Age and Ocular Hypertension Drive Incidence

By MedXY 04/23/2026

New study reveals 26.5-37.5% of eyes with pseudoexfoliation syndrome develop glaucoma within 4 years, with ocular hypertension doubling risk. Standalone lens extraction reduced IOP by 3 mmHg.

$LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia$

news Ophthalmology

LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia

By MedXY 03/19/2026

A new IOL power calculation formula, LISA MRS, demonstrates superior accuracy for cataract patients with prior myopic refractive surgery, significantly outperforming existing formulas in eyes with axial lengths of 28 mm or greater by utilizing posterior corneal radius data.

news Ophthalmology

Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes

By MedXY 03/16/2026

A longitudinal study of 603 patients demonstrates that chronic intravitreal anti-VEGF therapy significantly accelerates cataract development, particularly posterior subcapsular opacities, resulting in an eightfold increased risk for cataract surgery compared to untreated fellow eyes.

Allergy & Immunology news Ophthalmology

Institutional Policy Shifts on Penicillin Allergy Labels Dramatically Increase Cefuroxime Use in Cataract Surgery

By MedXY 03/13/2026

A large-scale quality improvement study reveals that reclassifying penicillin allergies and providing pharmacy support can increase the use of intracameral cefuroxime from 2% to over 70%, significantly improving evidence-based prophylaxis in cataract surgery.

Clinical Updates news Ophthalmology Specialties

Low-Level Light Therapy: A New Frontier in Preventing Dry Eye After Cataract Surgery

By MedXY 09/01/2025

Low-level light therapy, administered perioperatively, significantly reduces dry eye symptoms and preserves ocular surface integrity after cataract surgery, offering a noninvasive adjunct to standard care.